Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines

The recombinant adenoviruses contain in their genomes the sequence of the gene S of the transmissible porcine gastroenteritis virus or a sequence derived from said gene which contains, at least, one of the antigenic sites of the protein S of the transmissible porcine gastroenteritis virus. Said reco...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CRISTIAN SMERDOU, JUAN PLANA DURAN, LUIS ENJUANES, JUAN MARIA TORRES, CARLES SUNE, CARLOS MIGUEL SANCHEZ
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The recombinant adenoviruses contain in their genomes the sequence of the gene S of the transmissible porcine gastroenteritis virus or a sequence derived from said gene which contains, at least, one of the antigenic sites of the protein S of the transmissible porcine gastroenteritis virus. Said recombinant adenoviruses may be used in the formulation of vaccines in order to protect porcine cattle against the infection by the tansmissible porcine gastroenteritis virus and against the disease caused by said virus. This invention applies to the veterinary science.